Open access
Open access
Powered by Google Translator Translator

RCT: Central venous access devices (Hickman catheters vs. PICCs vs. PORTs) for the delivery of systemic anticancer therapy – “PORTs are more effective and safer than both Hickman and PICCs”.

21 Jul, 2021 | 10:42h | UTC

Central venous access devices for the delivery of systemic anticancer therapy (CAVA): a randomised controlled trial – The Lancet (link to abstract – $ for full-text)

News release: Study highlights more effective and safe way to deliver chemotherapy – University of Glasgow

 


Stay Updated in Your Specialty

No spam, just news.